Correlation Between NewAmsterdam Pharma and Immunome

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and Immunome at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and Immunome into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NewAmsterdam Pharma and Immunome, you can compare the effects of market volatilities on NewAmsterdam Pharma and Immunome and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of Immunome. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and Immunome.

Diversification Opportunities for NewAmsterdam Pharma and Immunome

-0.69
  Correlation Coefficient

Excellent diversification

The 3 months correlation between NewAmsterdam and Immunome is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and Immunome in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunome and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with Immunome. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunome has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and Immunome go up and down completely randomly.

Pair Corralation between NewAmsterdam Pharma and Immunome

Given the investment horizon of 90 days NewAmsterdam Pharma is expected to generate 1.76 times less return on investment than Immunome. But when comparing it to its historical volatility, NewAmsterdam Pharma is 1.19 times less risky than Immunome. It trades about 0.04 of its potential returns per unit of risk. Immunome is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  531.00  in Immunome on September 1, 2024 and sell it today you would earn a total of  824.00  from holding Immunome or generate 155.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

NewAmsterdam Pharma  vs.  Immunome

 Performance 
       Timeline  
NewAmsterdam Pharma 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in NewAmsterdam Pharma are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak primary indicators, NewAmsterdam Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.
Immunome 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Immunome has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Immunome is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

NewAmsterdam Pharma and Immunome Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NewAmsterdam Pharma and Immunome

The main advantage of trading using opposite NewAmsterdam Pharma and Immunome positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, Immunome can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunome will offset losses from the drop in Immunome's long position.
The idea behind NewAmsterdam Pharma and Immunome pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.